脱发区和恶性瘤:通过一项基于人口的大规模研究来澄清不确定性
Khalaf Kridin1,2,3, Rimma Laufer-Britva4,5, Francisco Jimenez6,7,8
1Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel. dr_kridin@hotmail.com.
Archives of dermatological research
|October 14, 2024
概括
脱发区 (AA) 与血液恶性瘤 (HMs) 相关,特别是非霍奇金淋巴瘤,但不是固体恶性瘤. 在晚期出现的AA病例中,这种关联更为强烈.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 大发脱发症 (AA) 与各种癌症之间的关系仍然存在争议,因为现有文献中的发现不一致.
- 以前的研究已经产生了相互矛盾的结果,关于AA和血液恶性瘤 (HMs) 或固体恶性瘤 (SMs) 之间的关联.
研究的目的:
- 调查大发性脱毛 (AA) 与血液性恶性瘤 (HMs) 和固体恶性瘤 (SMs) 的患病率之间的联系.
- 用一个大规模的,现实世界的计算机化数据库进行全面的分析.
主要方法:
- 采用了横截面研究设计.
- 年龄,性别和种族匹配的对照受试者与被诊断为AA的患者进行了比较.
- 统计分析包括奇平方测试,单变量分析的t测试和多变量分析的后勤回归.
主要成果:
- 在AA和HM之间发现了显著的关联 (调整后OR,1.27;P = 0.006).
- 这种关联在患有晚发性AA (≥50岁) 的患者中更为明显.
- 总体而言,AA与MS没有显著的关联 (调整后OR,0.97;P = 0.487),除了总体脱发和普遍性脱发亚型外.
- 非霍奇金淋巴瘤被确定为与AA积极相关的特定HM (调整后OR,1.32;P = 0.028).
结论:
- 大白发症与血液性恶性瘤的风险增加有显著的关联.
- 在AA和固体恶性瘤之间没有显著的关联,特定的亚型显示例外情况.
- 建议进行进一步的研究,以在不同患者队列中验证这些发现.
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
24
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
24
Skin Cancer
3.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.9K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K


